You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
0 of 1 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 points, (0)
Categories
Not categorized0%
1
Answered
Review
Question 1 of 1
1. Question
A cromolyn sodium(Intal) inhaler is prescribed for a client with allergic asthma. A nurse provides instructions regarding the side effects of this medication. The nurse tells that client that which undesirable effect is associated with this medication?
Correct
Answer & Rationale:
Option 4 is Correct
Rationale: Cromolyn sodium (Intal) is an inhaled nonsteroidal antiallergy agent and a mast cell stabilizer. Undesirable side effects associated with inhalation therapy of cromolyn sodium are bronchospasm, cough, nasal congestion, throat irritation, and wheezing. Clients receiving this medication orally may experience pruritus, nausea, diarrhea, and myalgia.
Incorrect
Answer & Rationale:
Option 4 is Correct
Rationale: Cromolyn sodium (Intal) is an inhaled nonsteroidal antiallergy agent and a mast cell stabilizer. Undesirable side effects associated with inhalation therapy of cromolyn sodium are bronchospasm, cough, nasal congestion, throat irritation, and wheezing. Clients receiving this medication orally may experience pruritus, nausea, diarrhea, and myalgia.
What is Cromolyn sodium (Intal)?
Cromolyn sodium (Intal) is an inhaled nonsteroidal antiallergy agent and a mast cell stabilizer. Undesirable side effects associated with inhalation therapy of cromolyn sodium are bronchospasm, cough, nasal congestion, throat irritation, and wheezing. Clients receiving this medication orally may experience pruritus, nausea, diarrhea, and myalgia.
Asthma treatment
Inhaled drugs commonly used in asthma treatment include b-adrenergic bronchodilators, cromolyn sodium, and aerosol
glucocorticoids. A, The metered-dose inhaler should not be put in the mouth but held about two fingerwidths (1½ inches) in front of the mouth. B, Alternatively, an inhaler with a spacer device can be used. Patients should breathe deeply once before activating the inhaler and then continue breathing in for about 5 seconds. Patients then should hold their breath for 10 to 15 seconds before breathing out slowly. If a second dose is needed, patients should wait 1 to 2 minutes before taking another dose.
